In a 72‑year‑old patient, are there any advantages or disadvantages to prescribing bupropion XL 150 mg twice daily versus bupropion XL 300 mg once daily?

Bupropion XL 300 mg Once Daily is Preferred in a 72-Year-Old Patient

In a 72-year-old patient, bupropion XL 300 mg once daily is the preferred dosing regimen over 150 mg twice daily, offering equivalent efficacy with superior medication adherence and reduced risk of dosing errors—critical considerations in elderly patients.

Rationale for Once-Daily Dosing

Adherence and Persistence Benefits

Research demonstrates that once-daily bupropion XL significantly improves medication persistence compared to twice-daily formulations. Patients taking bupropion XL showed nearly double the likelihood of maintaining adequate adherence (medication possession ratio >0.7) compared to twice-daily bupropion SR (32% vs 17%) 1. The mean duration between first and last prescription was 128 days for XL versus only 82 days for SR 1. In elderly patients, who often manage multiple medications and may have cognitive changes, simplified dosing schedules are particularly valuable for maintaining therapeutic benefit.

Equivalent Efficacy

The FDA-approved dosing for bupropion XL is 300 mg once daily in the morning, established through rigorous clinical trials 2. Bupropion XL 300 mg once daily provides equivalent 24-hour drug exposure to divided dosing regimens while maintaining therapeutic plasma levels throughout the day 3. The extended-release formulation achieves steady-state pharmacokinetics that support once-daily administration 3.

Age-Specific Considerations in 72-Year-Old Patients

Renal Function Monitoring

Because elderly patients are more likely to have decreased renal function, and bupropion and its metabolites are cleared renally, dose adjustment may be necessary 2. The FDA label specifically states that in patients with renal impairment (GFR <90 mL/min), consider reducing dose and/or frequency 2. However, this applies to reducing from 300 mg once daily if needed—not splitting to twice-daily dosing.

Safety Profile in Elderly

Clinical trials including 275 patients ≥65 years and 47 patients ≥75 years showed no overall differences in safety or effectiveness between elderly and younger subjects 2. A dedicated study in elderly patients with major depression confirmed that bupropion extended-release 150-300 mg once daily was effective and well-tolerated, with adverse events generally mild to moderate 4.

Timing Considerations

The second dose should not be taken late in the day to minimize insomnia risk 2. With once-daily morning dosing of 300 mg XL, this concern is eliminated entirely—a significant practical advantage in elderly patients who may already experience age-related sleep disturbances.

Practical Dosing Algorithm

Start with 150 mg XL once daily in the morning for 4 days, then increase to 300 mg XL once daily 2. This is the FDA-approved titration schedule.

When to Consider Dose Reduction (Not Splitting):

• Renal impairment: If GFR <90 mL/min, consider reducing to 150 mg once daily or every other day 2
• Hepatic impairment: Mild (Child-Pugh 5-6): consider dose reduction; Moderate-severe (Child-Pugh 7-15): maximum 150 mg every other day 2
• Tolerability issues: If adverse effects occur at 300 mg, reduce to 150 mg once daily rather than splitting doses

Common Pitfalls to Avoid

1. Do not prescribe "150 mg BID" for bupropion XL—this formulation is designed for once-daily dosing only. The XL formulation has different pharmacokinetics than SR formulations 3.

2. Do not confuse formulations: Bupropion SR (sustained-release) is dosed twice daily; bupropion XL (extended-release) is dosed once daily 2. These are not interchangeable on a per-dose basis.

3. Monitor for seizure risk factors: Bupropion lowers seizure threshold. It is contraindicated in patients with seizure disorders, and elderly patients with stroke or brain metastases should not receive it 5.

4. Assess renal function: Given age-related decline in renal function, check baseline creatinine/GFR before initiating therapy 2.

Disadvantages of Twice-Daily Dosing in This Population

• Increased risk of missed doses leading to subtherapeutic levels and treatment failure
• Higher pill burden in patients likely taking multiple medications
• Timing complexity with the second dose needing to be before 3 PM to avoid insomnia 6
• No therapeutic advantage over once-daily dosing
• Lower persistence rates documented in real-world studies 1

The evidence unequivocally supports bupropion XL 300 mg once daily as the optimal regimen for a 72-year-old patient, with dose reduction (not splitting) reserved for specific clinical circumstances like significant renal or hepatic impairment.